Evidence map›Paper›PMID 37533638›Full record

ArticleCell reports methods2023

Targeted proteomics data interpretation with DeepMRM.

Jungkap Park, Christopher Wilkins, Dmitry Avtonomov, Jiwon Hong, Seunghoon Back, Hokeun Kim, Nicholas Shulman, Brendan X MacLean, Sang-Won Lee, Sangtae Kim

Abstract read
In one paragraph

Article in Cell reports methods, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Proteomic approaches for interrogating kinase signaling networks.The Journal of investigative dermatology · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jungkap ParkBertis, Inc., Seoul 06108, Republic of Korea.
Christopher WilkinsBertis Bioscience, Inc., San Diego, CA 92121, USA.
Dmitry AvtonomovBertis Bioscience, Inc., San Diego, CA 92121, USA.
Jiwon HongDepartment of Chemistry, Center for Proteogenomic Research, Korea University, Seoul 02841, Republic of Korea.
Seunghoon BackDepartment of Chemistry, Center for Proteogenomic Research, Korea University, Seoul 02841, Republic of Korea.
Hokeun KimDepartment of Chemistry, Center for Proteogenomic Research, Korea University, Seoul 02841, Republic of Korea.
Nicholas ShulmanDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Brendan X MacLeanDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Sang-Won LeeDepartment of Chemistry, Center for Proteogenomic Research, Korea University, Seoul 02841, Republic of Korea.
Sangtae KimBertis Bioscience, Inc., San Diego, CA 92121, USA.

Funding

Seattle Quant: A Resource for the Skyline Software EcosystemR24GM141156 · NIGMS · UNIVERSITY OF WASHINGTON · PI Michael MacCoss · 2021 to 2026
$6.7M
NIGMS NIH HHS R24 GM141156
6 · The paper itself

Abstract

Targeted proteomics is widely utilized in clinical proteomics; however, researchers often devote substantial time to manual data interpretation, which hinders the transferability, reproducibility, and scalability of this approach. We introduce DeepMRM, a software package based on deep learning algorithms for object detection developed to minimize manual intervention in targeted proteomics data analysis. DeepMRM was evaluated on internal and public datasets, demonstrating superior accuracy compared with the community standard tool Skyline. To promote widespread adoption, we have incorporated a stand-alone graphical user interface for DeepMRM and integrated its algorithm into the Skyline software package as an external tool.

Indexed as

ProteomicsSoftwareAlgorithmsMass SpectrometryReproducibility of Resultsmachine learningmultiple reaction monitoringobject detectionpeak detectionquality controlquantificationselected reaction monitoringSkylinetargeted proteomics

Identifiers

PMID37533638
PMCPMC10391571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.